http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111728960-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2020-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-111728960-B |
titleOfInvention | Application of bisoprolol fumarate combined with docetaxel in the preparation of antitumor drugs |
abstract | The invention relates to the application of bisoprolol fumarate combined with docetaxel in the preparation of antitumor drugs. The combined use of bisoprolol fumarate and chemotherapy drug docetaxel has a significant synergistic effect, and can increase the antitumor effect of tumors on chemotherapy. Drug sensitivity, the combination of bisoprolol fumarate and chemotherapy drug docetaxel in patients with angina pectoris, arrhythmia and hypertension combined with cancer will play a "kill two birds with one stone" role at the same time. |
priorityDate | 2020-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.